AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

656.138

-6.217-0.94%

Number of Gainers:8

Number of Losers:17

Number of Flat:18

PE:- -

High:666.258

Open:660.539

Low:655.395

Close:662.355

Volume:61.41M

Turnover:116.52M

Market Cap:92.69B

Float Cap:89.39B

Loading ...

Clinuvel Pharmaceuticals Ltd-Clinuvel Considers NASDAQ Listing, ASX Delisting

THOMSON REUTERS

Clinuvel Pharmaceuticals Annual Franked Dividend of A$0.05 Per Ordinary Share

THOMSON REUTERS

Dimerix Posts Loss for Year Attributable of A$29.8 Million

Mesoblast FY26 Net Loss Narrows 44% to Us$57.5 Million; Revenue More than Doubled to Us$120.3 Million

Mesoblast Reports Substantial Revenue Growth to Us$120m

THOMSON REUTERS

Founder Led Stocks Retail Investors Are Tracking For Long Term Alignment

Simply Wall St.

Dimerix Ltd - Loss for the Year Attributable A$29.8 Mln

THOMSON REUTERS

Mesoblast Limited - There Can be no Assurance That We Will Ever Achieve or Maintain Profitability

THOMSON REUTERS

Mesoblast Limited - Anticipate That We May Continue to Incur Significant Losses for Foreseeable Future

THOMSON REUTERS

Mesoblast Ltd FY Revenue USD 120.3 Million

THOMSON REUTERS

Mesoblast Ltd FY Loss Attributable USD 57.5 Million

THOMSON REUTERS

ASX Growth Companies With High Insider Ownership Expecting 88% Earnings Growth

Simply Wall St.

3 ASX Growth Stocks With Strong Balance Sheets Investors May Want to Watch

Simply Wall St.

Botanix Pharmaceuticals Ltd - no Dividend was Declared or Paid During Year

THOMSON REUTERS

Botanix Pharmaceuticals Ltd - FY Net Loss Attributable A$69.8 Mln

THOMSON REUTERS

Invion Ltd - FY Prelim Revenues from Ordinary Activities A$384,707

THOMSON REUTERS

Invion Ltd - no Dividends Recommended or Declared During Current Financial Period

THOMSON REUTERS

Neuren Pharmaceuticals H1 Earnings Down; Royalty Income Up

MT Newswires Live

Starpharma FY Revenue AUD 12 Million

THOMSON REUTERS

Neuren Pharmaceuticals H1 Revenue AUD 42.7 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK7508/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":656.13776,"timestamp":1788155999504,"preClose":662.35516,"halted":0,"volume":61408438,"delay":0,"changeRate":-0.009387,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-6.217407,"latestTime":"08-31 16:00:00 AEST","open":660.5389,"high":666.2579,"low":655.3953,"amount":116520727,"amplitude":0.0164,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788134400000,1788156000000]],"turnoverRate":0.002409,"increases":7,"decrements":17,"flats":19,"marketCap":92694912137.5,"floatMarketCap":89392893767.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":666.2579,"amplitude":0.0164,"preClose":662.35516,"low":655.3953,"latestPrice":656.13776,"volume":61408438,"delay":0,"open":660.5389,"prevYearClose":644.3692,"prevWeekClose":662.355,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":657.516,"twentyDayClose":493.047,"sixtyDayClose":409.453,"secType":"PLATE","market":"AU","turnoverRate":0.002409,"marketCap":92694912137.5,"floatMarketCap":89392893767.375,"timestamp":1788155999504,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":8,"down":17,"flat":18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662372463","title":"Clinuvel Pharmaceuticals Ltd-Clinuvel Considers NASDAQ Listing, ASX Delisting","url":"https://stock-news.laohu8.com/highlight/detail?id=2662372463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662372463?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:33","pubTimestamp":1787797998,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUEBKRVRG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CUV.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662243347","title":"Clinuvel Pharmaceuticals Annual Franked Dividend of A$0.05 Per Ordinary Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662243347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662243347?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:24","pubTimestamp":1787797468,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXLD0576:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CUV.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662721510","title":"Dimerix Posts Loss for Year Attributable of A$29.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662721510","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662721510?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:49","pubTimestamp":1787795375,"startTime":"0","endTime":"0","summary":"Aug 27 (Reuters) - Dimerix Ltd::*LOSS FOR THE YEAR ATTRIBUTABLE A$29.8 MILLION*REVENUES FROM ORDINARY ACTIVITIES FOR THE YEAR A$7 MILLION*Further company coverage: DXB.AX* ((Reuters.Briefs@thomsonreut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nRSD9nJQBR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700725","title":"Mesoblast FY26 Net Loss Narrows 44% to Us$57.5 Million; Revenue More than Doubled to Us$120.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700725","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662700725?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:32","pubTimestamp":1787790751,"startTime":"0","endTime":"0","summary":"Mesoblast FY26 net loss narrows 44% to US$57.5 million; revenue more than doubled to US$120.3 millionMesoblast posted FY2026 revenue of US$120.3 million, up from US$17.2 million a year earlier, on Ryo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDLKTZvd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","BK4585","BK7508","LU2095319765.USD","LU2210149790.SGD","BK7501","BK7067","IE00BKPKM429.USD","MSB.AU","SG9999014013.SGD","IE00BQXX3D17.EUR","BCDF","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","LU0314104364.USD","SG9999014039.USD","BK4588","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014021.USD","BK4112","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662272574","title":"Mesoblast Reports Substantial Revenue Growth to Us$120m","url":"https://stock-news.laohu8.com/highlight/detail?id=2662272574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662272574?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:32","pubTimestamp":1787790727,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUABRVVHM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSB.AU","BK7501","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662727409","title":"Founder Led Stocks Retail Investors Are Tracking For Long Term Alignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662727409","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662727409?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:29","pubTimestamp":1787790593,"startTime":"0","endTime":"0","summary":"Central banks are still debating how far to push interest rates, which keeps a spotlight on companies that do not rely on cheap capital to grow. Founder led businesses often fit that profile because leaders usually think in decades, not quarters. That long term mindset can appeal to investors who want skin in the game. This article highlights three founder led stocks from the screener that show how that approach looks in practice.\nThe three founder led stocks below are just a starting sample,...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-retail-investors-are-tracking-for-long-te","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-retail-investors-are-tracking-for-long-te","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","MQG.AU","FLT.AU","BK7043","BK7070","BK4211","BK7511","ISBC","MAQ.AU","BK7046","BK7067","SPHQ","BK7501","BK7508","MSB.AU","BK4585","BK7042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662282967","title":"Dimerix Ltd - Loss for the Year Attributable A$29.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662282967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662282967?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:58","pubTimestamp":1787785108,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N17L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DXB.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740244","title":"Mesoblast Limited - There Can be no Assurance That We Will Ever Achieve or Maintain Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740244?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:25","pubTimestamp":1787783102,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0OW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","MSB.AU","BK4139","MESO","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740240","title":"Mesoblast Limited - Anticipate That We May Continue to Incur Significant Losses for Foreseeable Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740240?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:25","pubTimestamp":1787783102,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0OW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSB.AU","BK7501","BK7508","BK7067","BK4139","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662974029","title":"Mesoblast Ltd FY Revenue USD 120.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662974029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662974029?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:24","pubTimestamp":1787783049,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nPLXMK5SC6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740291","title":"Mesoblast Ltd FY Loss Attributable USD 57.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740291?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:24","pubTimestamp":1787783049,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nPLXMK5SC6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","BK7067","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662742635","title":"ASX Growth Companies With High Insider Ownership Expecting 88% Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662742635","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662742635?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:08","pubTimestamp":1787771298,"startTime":"0","endTime":"0","summary":"The Australian market is experiencing a positive trend, buoyed by falling oil prices and strong performances on Wall Street, with the S&P/ASX 200 recently crossing above its 20-day moving average. In this favorable environment, growth companies with high insider ownership can be particularly appealing to investors seeking potential earnings expansion, as they often demonstrate alignment between management and shareholder interests.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice1-main-header/1585186738088","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice1-main-header/1585186738088"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-hmc/hmc-capital-shares/news/asx-growth-companies-with-high-insider-ownership-expecting-8","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-hmc/hmc-capital-shares/news/asx-growth-companies-with-high-insider-ownership-expecting-8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FRS.AU","SKS.AU","BK7036","BK7116","PDI.AU","BK7096","BK7508","TPW.AU","WZR.AU","BK7501","BK7023","BK7095","BK7016","AR1.AU","BK7005","BK7093","BK7062","AWJ.AU","TTT.AU","BK7104","BK7162","AV1.AU","SPL.AU","BK7049","BK7110","AEM.AU","IPX.AU","BK7017","BK7107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662262744","title":"3 ASX Growth Stocks With Strong Balance Sheets Investors May Want to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662262744","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662262744?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:33","pubTimestamp":1787762029,"startTime":"0","endTime":"0","summary":"Central banks are still weighing further tightening as inflation proves stubborn, which keeps pressure on many companies. That backdrop makes earnings growth even more valuable. The Healthy high growth potential screener focuses on stocks where analysts expect strong earnings growth and balance sheets that can better handle higher rates. This article highlights three of the most compelling stocks from that screener to help you focus your research.\nThe stocks below are only a small sample,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/3-asx-growth-stocks-with-strong-balance-sheets-investors-may","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/3-asx-growth-stocks-with-strong-balance-sheets-investors-may","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7507","ISBC","FEBU","VOTE","BK7501","BK7067","LYC.AU","RGLO","BK7095","MVPS","GXDW","VGFPF","BK7508","PMDE","WGX.AU","DECU","MSB.AU","BK7506","BK7104","JOYT","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662879531","title":"Botanix Pharmaceuticals Ltd - no Dividend was Declared or Paid During Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2662879531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662879531?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:54","pubTimestamp":1787730880,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0GV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BOT.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795315","title":"Botanix Pharmaceuticals Ltd - FY Net Loss Attributable A$69.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795315","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795315?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:54","pubTimestamp":1787730880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","BK7508","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662953167","title":"Invion Ltd - FY Prelim Revenues from Ordinary Activities A$384,707","url":"https://stock-news.laohu8.com/highlight/detail?id=2662953167","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662953167?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:54","pubTimestamp":1787730865,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0E3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7508","IVX.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662311795","title":"Invion Ltd - no Dividends Recommended or Declared During Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2662311795","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662311795?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:54","pubTimestamp":1787730865,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0E3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVX.AU","BK7096","BK7508","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662763421","title":"Neuren Pharmaceuticals H1 Earnings Down; Royalty Income Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2662763421","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662763421?lang=en_us&edition=fundamental","pubTime":"2026-08-26 08:28","pubTimestamp":1787704117,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  logged AU$0.0381 in EPS for the first half of the year, compared with AU$0.1165 a year ago, a Wednesday filing showed.For the six months ended June 30, royalty income was AU$33.2 million versus AU$28.3 million previously, the Australia-listed pharmaceutical company added.The board declared an interim dividend of AU$0.15 per share, payable Oct. 7 to shareholders on record as of Sept. 16.The company expects royalties of $53 million to $56 million for the full year 2026 after partner Acadia lifted guidance for global DAYBUE net sales to $480 million to $510 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7096","NEU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662056768","title":"Starpharma FY Revenue AUD 12 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662056768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662056768?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:46","pubTimestamp":1787701578,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nPLXTR2ZQF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPL.AU","BK7096","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662684667","title":"Neuren Pharmaceuticals H1 Revenue AUD 42.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662684667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662684667?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:27","pubTimestamp":1787700422,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nPLXQDJSS5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NEU.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":156,"code":"91000000","status":"200"}]}}